StockDrifts LogoStockDrifts

Fibrillation 053060

Company
세동Fibrillation
Insiders
3
Buys
27
Total Value
₩843M ($586K)
Avg Return
+5.26%
Last Filing
2026-07-14

Fibrillation (053060) has 27 disclosed insider purchases and 0 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩843M ($586K) in reported transaction value. The earliest filing StockDrifts holds for Fibrillation is dated 2024-10-24; the most recent is 2026-07-14. Across these filings the average return since disclosure is +5.26%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-07-14BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO19.7K₩1,424+1.4%₩31M ($21K)
2026-07-14BUYMarket Buy
박영애
Park Young-ae
vice president33.8K₩1,424+1.4%₩53M ($37K)
2026-07-13BUYMarket Buy
박영애
Park Young-ae
vice president35.6K₩1,457-0.9%₩56M ($39K)
2026-07-13BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO20.5K₩1,457-0.9%₩32M ($22K)
2026-07-10BUYMarket Buy
박영애
Park Young-ae
vice president37.3K₩1,553-7.0%₩57M ($39K)
2026-07-10BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO21.6K₩1,553-7.0%₩33M ($23K)
2026-07-09BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO16.8K₩1,548-6.7%₩25M ($17K)
2026-07-09BUYMarket Buy
박영애
Park Young-ae
vice president28.9K₩1,548-6.7%₩43M ($30K)
2026-07-08BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO17.5K₩1,535-5.9%₩25M ($17K)
2026-07-08BUYMarket Buy
박영애
Park Young-ae
vice president30.2K₩1,535-5.9%₩43M ($30K)
2026-07-06BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO15.4K₩1,444+7.2%₩22M ($15K)
2026-07-06BUYMarket Buy
박영애
Park Young-ae
vice president26.5K₩1,444+7.2%₩38M ($27K)
2026-07-03BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO15.6K₩1,390+11.4%₩22M ($15K)
2026-07-03BUYMarket Buy
박영애
Park Young-ae
vice president26.8K₩1,390+11.4%₩37M ($26K)
2026-07-02BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO31.3K₩1,388+11.5%₩43M ($30K)
2026-07-02BUYMarket Buy
박영애
Park Young-ae
vice president51.7K₩1,388+11.5%₩72M ($50K)
2026-07-01BUYMarket Buy
박영애
Park Young-ae
vice president38.6K---
2026-07-01BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO27.8K---
2026-06-30BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO12.1K---
2026-06-30BUYMarket Buy
박영애
Park Young-ae
vice president20.1K---
2026-06-29BUYMarket Buy
윤 정 상
Yoon Jeong-sang
CEO12.4K---
2026-06-29BUYMarket Buy
박영애
Park Young-ae
vice president20.6K---
2026-06-17BUYMarket Buy
윤병선
Byungseon Yoon
vice president5.0K---
2025-04-02BUYMarket Buy
윤병선
Byungseon Yoon
vice president10.0K₩1,014+33.3%₩10M ($7K)
2024-10-28BUYMarket Buy
윤 정 상
Yoon Jeong-sang
Compliance Division/88.0K₩1,177+14.9%₩104M ($72K)
2024-10-25BUYMarket Buy
윤 정 상
Yoon Jeong-sang
Compliance Division/56.0K₩1,155+17.1%₩65M ($45K)
2024-10-24BUYMarket Buy
윤 정 상
Yoon Jeong-sang
Compliance Division/28.8K₩1,145+18.1%₩33M ($23K)

Frequently asked questions

Who has been buying Fibrillation stock?
3 distinct insiders have filed 27 disclosed insider purchases in Fibrillation (053060), most recently on 2026-07-14. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Fibrillation have?
Fibrillation has 27 buy-side and 0 sell-side disclosures on record, covering ₩843M ($586K) in total reported value, spanning 2024-10-24 to 2026-07-14.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.